Nextgen Biomed Ltd
Tel Aviv Stock Exchange NXGN.TA
Nextgen Biomed Ltd Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.17
Nextgen Biomed Ltd Free Cash Flow Per Share is USD -0.17 for the year ending December 31, 2023, a -832.48% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
-
Nextgen Biomed Ltd Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.02, a 29.54% change year over year.
-
Nextgen Biomed Ltd Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.03, a -72.90% change year over year.
-
Nextgen Biomed Ltd Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.01.
Key data
| Date | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA
| CEO | Mr. Harel Hershtik |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | 132 Azrieli Towers Round Building |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email